Search for: "Astrazeneca PLC"
Results 81 - 95
of 95
Sorted by Relevance
|
Sort by Date
6 Jul 2017, 9:30 pm
AstraZeneca Plc, the appellant in the case, reportedly argued that the doctrine made it too easy for drug companies to lose patents. [read post]
17 Jul 2007, 2:01 pm
IBM Corp. said Monday it has won a $1.4 billion outsourcing contract from AstraZeneca PLC, a seven-year deal aimed at helping the British pharmaceutical company manage its internal technology operations. [read post]
6 Mar 2014, 12:41 pm
Glaxo Wellcome PLC, 246 F.3d 934 (7th Cir. 2001). [read post]
29 Jun 2006, 5:04 pm
In August, AstraZeneca Plc. announced that adding its investigational non-small cell lung cancer (NSCLC) drug Iressa to standard therapy did not improve survival in a phase III trial of patients who had failed prior chemotherapy. [read post]
22 Jun 2014, 9:01 pm
Recently, the news reported that Pfizer, Inc. wants to buy a British rival, AstraZeneca, PLC for nearly $100 billion. [read post]
5 May 2010, 10:14 pm
Cir. 2001); see Astrazeneca Pharms. [read post]
11 Jan 2022, 11:45 am
In 2015, AstraZeneca and Cephalon paid a total of $54 million to resolve claims that they also improperly reduced AMPs by wrongfully accounting for service fees they paid to wholesalers. [read post]
11 Jan 2022, 11:45 am
In 2015, AstraZeneca and Cephalon paid a total of $54 million to resolve claims that they also improperly reduced AMPs by wrongfully accounting for service fees they paid to wholesalers. [read post]
24 Sep 2010, 7:00 am
., August 20, 2010): In this case, the SEC alleges that Garcia and Sanchez engaged in insider trading in call options contracts of Potash Corp. just prior to an August 17, 2010 public announcement by Potash that it had received and rejected an unsolicited proposal from BHP Billiton Plc to acquire Potash’s stock for $130 per share. [read post]
2 Aug 2008, 12:54 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
29 Feb 2008, 8:00 am
., claiming infringement of three patents covering its enlarged-prostate treatment, Avodart; Barr challenges GSK’s Avodart patent: (IP Law360), (GenericsWeb),Fosamax (Alendronate) – Courts in Netherlands and France both invalidate Merck Sharp & Dohme’s European patents for Alendronate: (IP Law360), (The IP Factor), (Generic Pharmaceuticals & IP), Hectorol – Genzyme Corp launches US patent suit against Pentech Pharmaceuticals to prevent it from… [read post]
28 Apr 2010, 10:51 am
See Astrazeneca Pharm. [read post]
28 Apr 2008, 11:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC vacates FTC’s decision that Rambus breached antitrust duty by violating JEDEC patent disclosure rules and orders new trial: (Philip Brooks), (Techdirt), (Ars Technica), (IP Law360), (Peter Zura's 271 Patent Blog), (Hal Wegner), (IPBiz), (IP Law360), UK Court of Appeal rules on whether prior art not in the same design field… [read post]
22 Feb 2008, 6:00 pm
: (Patent Baristas),Vietnam : new developments in patent protection for medical uses: (Patent Docs),Wisconsin Alumni Research Foundation licenses stem cell patents to BioTime: (IPBiz)Pharma & Biotech - ProductsFloxin (Ofloxacin) –US Supreme Court declines Daiichi Sankyo’s request for appeal of CAFC decision reversing Daichii’s initial win in its ofloxacin patent infringement case against Apotex: (IP Law360),Galvus (Vildagliptin) – Indian patent granted… [read post]
3 Jan 2023, 1:47 pm
The directors’ and officers’ liability environment is always changing, but 2022 was a particularly eventful year, with important consequences for the D&O insurance marketplace. [read post]
